MARK4 anticorps (C-Term)

N° du produit ABIN359301

Détail du produit anti-MARK4 anticorps

Antigène: MARK4 (MAP/microtubule Affinity-Regulating Kinase 4 (MARK4))

Épitope: C-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MARK4 est non-conjugé

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Specificité: This antibody reacts to MARK4.

Purification: Protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS

Immunogène: This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the C-terminal region of human MARK4.

Isotype: Ig Fraction

Information d'application

Indications d'application: ELISA: 1/1,000. Western blotting: 1/100 - 1/500.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.25 mg/mL

Buffer: PBS with 0.09 % (W/V) sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.

Détails sur MARK4

Antigène: MARK4 (MAP/microtubule Affinity-Regulating Kinase 4 (MARK4))

Autre désignation: MARK4 (MARK4 Produits)

Synonymes: anticorps MARK4, anticorps MARK4L, anticorps MARK4S, anticorps MARKL1, anticorps MARKL1L, anticorps PAR-1D, anticorps 2410090P21Rik, anticorps C79806, anticorps Markl1, anticorps microtubule affinity regulating kinase 4, anticorps MAP/microtubule affinity regulating kinase 4, anticorps MARK4, anticorps Mark4

Sujet: MARK4 contains an N-terminal serine/threonine kinase domain, a central ubiquitin-associated domain, and a C-terminal KA1-associated kinase domain. RT-PCR analysis detects upregulated expression of the gene for MARK4 in nearly all clinical hepatocellular carcinoma cells. Northern blot analysis reveals ubiquitous expression of a 3.6-kb transcript, with highest expression in testis. Immunofluorescence microscopy demonstrates homogeneous cytoplasmic expression. Colony-forming assays show that MARK4 antisense reduces the growth of SNU475 cells. It has been suggested that MARK4 provides a growth advantage to cells.Synonyms: MAP microtubule affinity-regulating kinase 4, MARKL1

ID gène: 57787

NCBI Accession: NP_001186796

UniProt: Q96L34